|March 2011 · Vol. 23, No. 3
UPDATE ON CERVICAL DISEASE
Guidance on HPV vaccination, cervical cancer screening, and colposcopically directed biopsy
Dr. Cox is Past President of the American Society for Colposcopy and Cervical Pathology and serves as an OBG Management Contributing Editor.
Dr. Cox is a consultant to Gen-Probe and Roche, and serves on the Data and Safety Monitoring Committee (DSMB) for Merck HPV vaccine trials. He is a speaker for Glaxo Smith Kline.
Over the past year, we have gained further insight into the efficacy and safety of the human papillomavirus (HPV) vaccines; received new, practical cervical screening guidance from the Centers for Disease Control and Prevention (CDC); and gathered further evidence that colposcopy is not as sensitive at detecting high-grade cervical disease as we once thought.